ArticleCancer gene therapy2023

Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer.

D C A Quixabeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.